Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management

    August 2021 in “ JAAD International ”
    Michela Starace, Matilde Iorizzo, Andrea Sechi … Bianca Maria Piraccini
    Studysummary This study found that telogen effluvium and trichodynia are common in patients after COVID-19, and their severity may be influenced by the severity of the COVID-19 infection.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaadinternational.org →
    Discuss this study in the Community →

    Research cited in this study 22

    1. Telogen Effluvium Associated with COVID-19 Infection Dermatologic Therapy · 2021
    2. The Role of Sleep in Telogen Effluvium and Trichodynia: A Commentary in the Context of the Current Pandemic Journal of Cosmetic Dermatology · 2021
    3. What Can Hair Tell Us About COVID-19? Experimental Dermatology · 2020
    4. A Surge in the Incidence of Telogen Effluvium in Minority Predominant Communities Heavily Impacted by COVID-19 Journal of The American Academy of Dermatology · 2020
    5. Telogen Effluvium: A Sequela of COVID-19 International Journal of Dermatology · 2020
    6. SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study Journal of the European Academy of Dermatology and Venereology · 2020
    7. Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience Dermatologic Therapy · 2020
    8. Acute Telogen Effluvium Associated with SARS-CoV-2 Infection AJGP · 2020
    9. Relative Changes in the Pattern of Diseases Presenting in Dermatology Outpatient Clinic in the Era of the COVID-19 Pandemic Dermatologic Therapy · 2020
    10. Evaluation of the Effects of COVID-19 Pandemic on Hair Diseases Through a Web-Based Questionnaire Dermatologic Therapy · 2020
    11. Management of Telogen Effluvium During the COVID-19 Emergency: Psychological Implications Dermatologic Therapy · 2020
    12. Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature Drugs - Real World Outcomes · 2016
    13. Telogen Effluvium: Is There a Need for a New Classification Skin appendage disorders · 2016
    14. Chronic Telogen Effluvium Is Due to a Reduction in the Variance of Anagen Duration Australasian Journal of Dermatology · 2010
    15. Trichodynia Is a Distinguishing Symptom of Telogen Effluvium Journal of the European Academy of Dermatology and Venereology · 2009
    16. Diffuse Hair Loss in an Adult Female: Approach to Diagnosis and Management Indian Journal of Dermatology, Venereology and Leprology · 2009
    17. The Presence of Trichodynia in Patients With Telogen Effluvium and Androgenetic Alopecia International Journal of Dermatology · 2003
    18. Hair Pain (Trichodynia): Frequency and Relationship to Hair Loss and Patient Gender Dermatology · 2002
    19. Telogen Effluvium and Trichodynia PubMed · 1998
    20. Interleukin-1β Is Differentially Expressed by Human Dermal Papilla Cells in Response to PKC Activation and Is a Potent Inhibitor of Human Hair Follicle Growth in Organ Culture Journal of interferon & cytokine research · 1997
    21. Telogen Effluvium: New Concepts and Review Archives of Dermatology · 1993
    22. Telogen Effluvium: A Comprehensive Review Archives of Dermatology · 1993